Peripheral Embolization Coils Market Scope And Analysis

Peripheral Embolization Coils Market Report Scope

Peripheral Embolization Coils Market News and Recent Developments

The peripheral embolization coils market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the market are mentioned below:

• Zylox-Tonbridge Medical Technology Co., Ltd. received marketing approval for its ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System from the National Medical Products Administration (NMPA). ZYLOX Phoenix is a proprietary medical device independently developed by the company for the minimally invasive interventional treatment of peripheral arterial embolism. (ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO LTD., Press Release, January 2024)
• Boston Scientific Corporation received US Food and Drug Administration (FDA) 510(k) clearance for the EMBOLD Fibered Detachable Coil, which is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. (Coloplast Group, Press Release, April 2022)
• Wallaby Medical announced the acquisition of phenox GmbH—including femtos GmbH (femtos), a Germany-based global innovation and technology leader in the neurovascular space. The acquisition has been one of the world’s largest cross-border transactions in the medical device industry in recent years. It would enable the combined company to leverage the broad geographic coverage and product portfolio of participant companies to become a global leader in providing a wide range of neurovascular technologies and solutions to its customers and patients in the US, China, Europe, Japan, and other international markets. (Wallaby Medical, Press Release, April 2022)
• Wallaby Medical Holding, Inc. received approval from the National Medical Products Administration (NMPA) to market its Avenir Plus Coil System in China. The product was developed independently by Wallaby with the objective of safely and efficiently achieving a dense packing of aneurysms, isolating them from blood flow, and lowering the risk of future rupture or re-rupture. Smaller, softer coils included in the new Avenir Plus Coil System assist physicians in achieving such dense packing. (Wallaby Medical, Press Release, April 2022)

Peripheral Embolization Coils Market Report Coverage and Deliverables

The “Peripheral Embolization Coils Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:

• Peripheral embolization coils market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Peripheral embolization coils market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Peripheral embolization coils market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the peripheral embolization coils market
• Detailed company profiles